CA2176145A1 - Biocompatible ocular implants - Google Patents

Biocompatible ocular implants

Info

Publication number
CA2176145A1
CA2176145A1 CA002176145A CA2176145A CA2176145A1 CA 2176145 A1 CA2176145 A1 CA 2176145A1 CA 002176145 A CA002176145 A CA 002176145A CA 2176145 A CA2176145 A CA 2176145A CA 2176145 A1 CA2176145 A1 CA 2176145A1
Authority
CA
Canada
Prior art keywords
ocular implants
administration
implants
biocompatible ocular
biocompatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002176145A
Other languages
French (fr)
Other versions
CA2176145C (en
Inventor
Vernon G. Wong
Frank Kochinke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/153,184 external-priority patent/US5443505A/en
Application filed by Individual filed Critical Individual
Publication of CA2176145A1 publication Critical patent/CA2176145A1/en
Application granted granted Critical
Publication of CA2176145C publication Critical patent/CA2176145C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Implants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drugs is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration.
CA002176145A 1993-11-15 1994-11-09 Biocompatible ocular implants Expired - Lifetime CA2176145C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/153,184 1993-11-15
US08/153,184 US5443505A (en) 1993-11-15 1993-11-15 Biocompatible ocular implants
PCT/US1994/012898 WO1995013765A1 (en) 1993-11-15 1994-11-09 Biocompatible ocular implants

Publications (2)

Publication Number Publication Date
CA2176145A1 true CA2176145A1 (en) 1995-05-26
CA2176145C CA2176145C (en) 2007-04-10

Family

ID=38007156

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002176145A Expired - Lifetime CA2176145C (en) 1993-11-15 1994-11-09 Biocompatible ocular implants

Country Status (1)

Country Link
CA (1) CA2176145C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US11690807B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US11690807B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US11951215B2 (en) 2018-05-24 2024-04-09 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Also Published As

Publication number Publication date
CA2176145C (en) 2007-04-10

Similar Documents

Publication Publication Date Title
TW368411B (en) Biocompatible ocular implants
CA2030459A1 (en) Biodegradable ocular implants
EP0322319A3 (en) Composition comprising biodegradable ocular implants
GB2264640B (en) Microcrystalline cellulose spheroids comprising hydromorphone and a sugar
FR2739783B1 (en) DEFIBRILLATOR / ACTIVE IMPLANTABLE CARDIOVERVER MEDICAL DEVICE WITH HEADSET DEFIBRILLATION
CA2111193A1 (en) Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
AU6833090A (en) Two-part device for the controlled delivery of an active ingredient
CA2257976A1 (en) Compositions and methods for coating medical devices
CA2233043A1 (en) Port body for the administration of drugs
CA2087420A1 (en) Ophthalmic pharmaceutical composition containing n-acetyl-cisteine and polyvinylalcohol
AU7594794A (en) Surgical suture needle of the taper point type
USD361555S (en) Combined programmer and monitor for an implantable tissue growth stimulator
TW234691B (en)
CA2294921A1 (en) Levobupivacaine and its use
WO2003015667A8 (en) Method and intra sclera implant for treatment of glaucoma and presbyopia
CA2154103A1 (en) Treatment of Mucous Membrane Disease, Trauma or Condition and for the Relief of Pain
CA2190303A1 (en) Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
CA2176145A1 (en) Biocompatible ocular implants
AU3401093A (en) Therapeutic agent for threatened abortion
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
CA2228266A1 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
DE69100171D1 (en) SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
USD353889S (en) Implantable tissue growth stimulator
UA30143A (en) MEDICAL DRUG FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20141110